Reiter's syndrome following intravesical BCG immunotherapy

Postgraduate Medical Journal

Volumn 76, Issue 902, 2000, Pages 791-793

  Hogarth, M B ^a   Thomas, S ^a   Seifert, M H ^a   Tariq, S M ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Arthritis; BCG immunotherapy; Reiter's syndrome

Indexed keywords

BCG VACCINE; DICLOFENAC; ISONIAZID; PREDNISOLONE; PYRIDOXINE;

AGED; ARTICLE; BLADDER CARCINOMA; CASE REPORT; CLINICAL FEATURE; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; PHYSICAL EXAMINATION; REITER SYNDROME; SKIN TEST; TRANSITIONAL CELL CARCINOMA;

AGED; ARTHRITIS, REACTIVE; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; REITER SYNDROME; URINARY BLADDER NEOPLASMS;

EID: 0034528947     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.76.902.791     Document Type: Article

References (10)

1. BCG immunotherapy of bladder cancer
2. Complications of Bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer
3. Experimental models in rheumatoid disease
4. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans
5. Reiter's syndrome after intravesical Bacillus Calmette-Guerin treatment for superficial bladder carcinoma
6. Reiter syndrome following intracavitory BCG administration
7. Epididymo-orchitis and Reiter's disease. Two infrequent complications after intravesical Bacillus Calmette-Guerin therapy
8. Evidence for an HLA DR4 associated immune response gene for mycobacterium tuberculosis
9. Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig
10. Effects of isoniazid (INH) on the BCG induced local immune response after intravesical BCG therapy for superficial bladder cancer